Browse All

Current Filters

CLEAR FILTER x

TITLE

Facilitated Subcutaneous Immunoglobulin 10% for CIDP: Interim Results from a Long-term Safety and Tolerability Study

Author:Hadden, Robert DM   Andersen, Henning   Bril, Vera   Basta, Ivana   Rejdak, Konrad   Djordjevic, Gordana   Greco, Erin   Hasan, Shabbir   French, James   Yel, Leman   Ay, Hakan   

Session Name:S15: Autoimmune Neuromuscular Diseases: New Observations and Therapeutic Approaches  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S15.007  

Author Institution:Neurology Department, King’s College Hospital, London, United Kingdom  Aarhus University, Aarhus , Denmark  The Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, University of Toronto, Toronto, ON, Canada  University of Belgrade, Faculty of Medicine, Neurology Clinic, University Clinical Center of Serbia, Belgrade, Serbia  Department of Neurology, Medical University of Lublin, Lublin, Poland  Neurology Clinic, University Clinical Center of Nis, Nis, Serbia  Takeda Development Center Americas, Inc., Cambridge, MA  

Health Outcomes Stratified by Number of Adverse Events Experienced by Patients with Dravet Syndrome: Insights from a Global Real-world Study

Author:Shah, Drishti   Andrews, J. Scott   Benitez, Arturo   DeCourcy, Jonathan   Taylor, Yasmin   Connolly, Hannah   Lai, Sophie   Villanueva, Vicente   

Session Name:P2: Epilepsy/Clinical Neurophysiology (EEG): Pediatric Epilepsy 2  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P2.005  

Author Institution:Takeda Development Center Americas, Inc., Cambridge, MA  Adelphi Real World, Bollington, United Kingdom  Hospital Universitario y Politécnico La Fe, Valencia, Spain  

Patient-reported Outcomes with Hyaluronidase-facilitated Subcutaneous Immunoglobulin 10% Maintenance Therapy for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Author:Anderson-Smits, Colin   French, James   Hasan, Shabbir   Greco, Erin   Ay, Hakan   

Session Name:P9: Neuromuscular and Clinical Neurophysiology (EMG): Immune Mediated Neuropathies  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P9.002  

Author Institution:Takeda Development Center Americas, Inc., Cambridge, MA  

Proposed Mechanism of Action of Soticlestat as an Antiseizure Medication

Author:Murthy, Naga Venkatesha   Asgharnejad, Mahnaz   Benitez, Arturo   Nakashima, Kosuke   Kondo, Shinichi   

Session Name:P9: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Mechanisms, Pharmacokinetics, and Urgent Applications  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P9.013  

Author Institution:Takeda Development Center Americas, Inc., Cambridge, MA  Takeda Pharmaceutical Company Ltd, Fujisawa, Japan